{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T05:34:57Z","timestamp":1773725697765,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011408","name":"Subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"MSD R&D (China) Co., Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.018","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T07:30:46Z","timestamp":1551079846000},"page":"1836-1843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Immunogenicity of pentavalent rotavirus vaccine in Chinese infants"],"prefix":"10.1016","volume":"37","author":[{"given":"Zhaojun","family":"Mo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minghuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darcy A.","family":"Hille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth A.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2019.02.018_b0005","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.018_b0010","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1016\/j.vaccine.2011.07.104","article-title":"Hospital-based study of the economic burden associated with rotavirus diarrhea in eastern China","volume":"29","author":"Jin","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.018_b0015","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/INF.0000000000000799","article-title":"Rotavirus-specific and overall diarrhea mortality in Chinese children younger than 5 years: 2003 to 2012","volume":"34","author":"Zhang","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0020","unstructured":"Meeting of the immunization Strategic Advisory Group of Experts, April 2009--conclusions and recommendations. Wkly Epidemiol Rec 2009;84:220-36"},{"issue":"84","key":"10.1016\/j.vaccine.2019.02.018_b0025","first-page":"517","article-title":"conclusions and recommendations","volume":"2009","author":"Meeting of the Strategic Advisory Group of Experts on immunization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2019.02.018_b0030","unstructured":"PATH. Global introduction status, 2018 [accessed on 30 Nov 2018] <http:\/\/rotacouncil.org\/vaccine-introduction\/global-introduction-status\/>."},{"key":"10.1016\/j.vaccine.2019.02.018_b0035","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1097\/INF.0000000000001327","article-title":"The Public health burden of rotavirus disease in children younger than five years and considerations for rotavirus vaccine introduction in China","volume":"35","author":"Wu","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0040","first-page":"170","article-title":"Genotype of rotavirus vaccine strain LLR in China is G10P[15]","volume":"31","author":"Li","year":"2015","journal-title":"Chinese J Virol"},{"key":"10.1016\/j.vaccine.2019.02.018_b0045","first-page":"CD008521","article-title":"Vaccines for preventing rotavirus diarrhoea: vaccines in use","volume":"11","author":"Soares-Weiser","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2019.02.018_b0050","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4161\/hv.6.11.12847","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis: further analysis and update","volume":"6","author":"Fu","year":"2010","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2019.02.018_b0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.vaccine.2012.10.078","article-title":"Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children","volume":"31","author":"Fu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.018_b0060","first-page":"256","article-title":"The utility of Lanzhou Lamb rotavirus vaccine among children under 5 in two vaccination sites of Shenzhen","volume":"29","author":"Liu","year":"2015","journal-title":"Chinese J Experiment Clin Virol"},{"key":"10.1016\/j.vaccine.2019.02.018_b0065","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2015.64","article-title":"Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design","volume":"4","author":"Zhen","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2019.02.018_b0070","doi-asserted-by":"crossref","first-page":"e181382","DOI":"10.1001\/jamanetworkopen.2018.1382","article-title":"Rotavirus gastroenteritis infection among children vaccinated and unvaccinated with rotavirus vaccine in Southern China: a population-based assessment","volume":"1","author":"Fu","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2019.02.018_b0075","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1016\/j.vaccine.2017.08.081","article-title":"Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial","volume":"35","author":"Mo","year":"2017","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.02.018_b0080","first-page":"A106","article-title":"Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia","volume":"30","author":"Shin","year":"2012","journal-title":"Bangladesh and Vietnam. Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.02.018_b0085","doi-asserted-by":"crossref","first-page":"A86","DOI":"10.1016\/j.vaccine.2011.10.006","article-title":"Immunogenicity of the pentavalent rotavirus vaccine in African infants","volume":"30","author":"Armah","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.018_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/sim.4780040211","article-title":"Comparative analysis of two rates","volume":"4","author":"Miettinen","year":"1985","journal-title":"Stat Med"},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2019.02.018_b0095","doi-asserted-by":"crossref","first-page":"G72","DOI":"10.1016\/j.vaccine.2009.09.107","article-title":"Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine","volume":"27","author":"Ciarlet","year":"2009","journal-title":"RotaTeq. Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.018_b0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1086\/514076","article-title":"Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group","volume":"176","author":"Ward","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.018_b0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/infdis\/jit166","article-title":"A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy","volume":"208","author":"Patel","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.018_b0110","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4161\/hv.27097","article-title":"Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis","volume":"10","author":"Cheuvart","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.018_b0115","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1080\/21645515.2017.1356522","article-title":"Postdose 3 G1 serum neutralizing antibody as correlate of protection for pentavalent rotavirus vaccine","volume":"13","author":"Liu","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.018_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.02.018_b0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.2006-2058","article-title":"Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life","volume":"119","author":"Block","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2019.02.018_b0130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0929-6646(09)60067-X","article-title":"Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan","volume":"108","author":"Chang","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.vaccine.2019.02.018_b0135","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/INF.0b013e3181782780","article-title":"Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine","volume":"27","author":"Ciarlet","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0b013e31818c0161","article-title":"Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity","volume":"28","author":"Ciarlet","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0b013e31815aba79","article-title":"Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea","volume":"27","author":"Kim","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0150","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.02.018_b0155","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.018_b0160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/21645515.2015.1085143","article-title":"Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants","volume":"12","author":"Li","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.018_b0165","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000254391.71103.e8","article-title":"Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States","volume":"26","author":"Rodriguez","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0170","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","article-title":"Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2019.02.018_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1279769","article-title":"Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants","volume":"13","author":"Tanaka","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.02.018_b0180","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1093\/infdis\/jiw574","article-title":"Experience with inactivated polio vaccine introduction and the \u201cswitch\u201d from trivalent to bivalent oral polio Vaccine in the World Health Organization's Western Pacific Region","volume":"216","author":"Gurung","year":"2017","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T14:30:58Z","timestamp":1662993058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302130"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity of pentavalent rotavirus vaccine in Chinese infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}